STAGE III BLADDER CANCER AJCC V8
Clinical trials for STAGE III BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted pill trial offers new hope for Tough-to-Treat urinary cancers
Disease control Recruiting nowThis study is testing whether a pill called olaparib can help control advanced bladder and other urinary cancers that have specific genetic problems in their DNA repair system. It is for patients whose cancer has spread or worsened despite prior treatments like chemotherapy or im…
Matched conditions: STAGE III BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 05:20 UTC
-
New attack on tough cancers: drugs then surgery
Disease control Recruiting nowThis study is for people with advanced bladder or upper urinary tract cancer that has spread. It tests if using two standard cancer drugs first, followed by surgery to remove the bladder or ureter, helps control the cancer better and for longer. The goal is to see if this combine…
Matched conditions: STAGE III BLADDER CANCER AJCC V8
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New support program aims to help bladder cancer patients navigate complex treatment
Symptom relief Recruiting nowThis study is testing an education and navigation support tool designed to help patients with advanced bladder cancer and their caregivers participate more actively in treatment decisions and care planning. The program provides educational resources, connects patients to support …
Matched conditions: STAGE III BLADDER CANCER AJCC V8
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Feb 17, 2026 14:36 UTC